FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Silvana Canevari

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Maurizio Callari; Silvana Canevari; Elena Cavadini; Maria Grazia Daidone; Loris De Cecco; Matteo Dugo; Chiara Ghimenti; Paola Tiberio; Valentina Appierto
Feasibility of circulating miRNA microarray analysis from archival plasma samples.
Grazia Carbotti; Maria Grazia Centurioni; Laura Emionite; Marina Bagnoli; Antonella Brizzolara; Milena Bruzzone; Silvana Canevari; Silvano Ferrini; Paola Marroni; Delia Mezzanzanica; Anna Maria Orengo; Andrea Puppo; Armando Rossello; Marina Fabbi
Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
Maura Sonego; Barbara Valeri; Marina Bagnoli; Mattia Barbareschi; Barbara Belletti; Silvana Canevari; Vincenzo Canzonieri; Alfonso Colombatti; Alessandra Dall'acqua; Sara D'Andrea; Giannino Del Sal; Giorgio Giorda; Massimo Libra; Francesca Lovat; Sara Lovisa; Delia Mezzanzanica; Loredana Militello; Marco Napoli; Barbara Pivetta; Monica Schiappacassi; Gustavo Baldassarre
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Silvana Canevari (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Maurizio Callari; Silvana Canevari; Elena Cavadini; Maria Grazia Daidone; Loris De Cecco; Matteo Dugo; Chiara Ghimenti; Paola Tiberio; Valentina Appierto
Feasibility of circulating miRNA microarray analysis from archival plasma samples.
Analytical biochemistry 2013;437(2):123-5.
2013: Grazia Carbotti; Maria Grazia Centurioni; Laura Emionite; Marina Bagnoli; Antonella Brizzolara; Milena Bruzzone; Silvana Canevari; Silvano Ferrini; Paola Marroni; Delia Mezzanzanica; Anna Maria Orengo; Andrea Puppo; Armando Rossello; Marina Fabbi
Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
International journal of cancer. Journal international du cancer 2013;132(11):2597-605.
2013: Maura Sonego; Barbara Valeri; Marina Bagnoli; Mattia Barbareschi; Barbara Belletti; Silvana Canevari; Vincenzo Canzonieri; Alfonso Colombatti; Alessandra Dall'acqua; Sara D'Andrea; Giannino Del Sal; Giorgio Giorda; Massimo Libra; Francesca Lovat; Sara Lovisa; Delia Mezzanzanica; Loredana Militello; Marco Napoli; Barbara Pivetta; Monica Schiappacassi; Gustavo Baldassarre
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.
EMBO molecular medicine 2013;5(5):707-22.
2013: Alessandro Satta; Fabio Turatti; Silvana Canevari; Delia Mezzanzanica; Mariangela Figini
Redirection of T-cell effector functions for cancer therapy: bispecific antibodies and chimeric antigen receptors.
Future oncology (London, England) 2013;9(4):527-39.
2012: Rossella Canese; Silvana Canevari; Albino Cesolini; Massimo Giannini; Marina Bagnoli; Delia Mezzanzanica; Luisa Paris; Maria Elena Pisanu; Franca Podo; Alessandro Ricci; Andrea Rodomonte; Massimo Spada; Barbara Valeri; Massimo Venditti; Egidio Iorio
Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.
NMR in biomedicine 2012;25(4):632-42.
2012: Paola Perego; Stella Tinelli; Nadia Zaffaroni; Franco Zunino; Silvana Canevari; Nives Carenini; Emilio Ciusani; Elisabetta Corna; Giacomo Cossa; Michelandrea De Cesare; Laura Gatti; Elena Luison; Giovanni Luca Beretta
Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition.
Biochemical pharmacology 2012;83(1):27-36.
2011: Marina Bagnoli; Mattia Barbareschi; Paola Alberti; Loris De Cecco; Anna Granata; Massimo Libra; Edoardo Marchesi; Delia Mezzanzanica; Roberta Nicoletti; Francesco Raspagliesi; Barbara Valeri; Silvana Canevari
Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients.
Oncotarget 2011;2(12):1265-78.
2011: Alberto Zacchetti; Marcello Allegretti; Emilio Bombardieri; Angela Coliva; Mariangela Figini; Elena Luison; Franck Martin; Silvana Canevari
Antitumor effects of a human dimeric antibody fragment 131I-AFRA-DFM5.3 in a mouse model for ovarian cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(12):1938-46.
2011: Marialuisa Sensi; Antonella Tomassetti; Gabrina Tragni; Federica Alciato; Giancarlo Avanzi; Ilaria Bersani; Silvana Canevari; Giancarlo Castellano; Mara Catani; Giuseppina De Santis; Gabriella Nicolini; Andrea Anichini
Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase.
The Journal of investigative dermatology 2011;131(12):2448-57.
2011: Anna Maria Orengo; Tiziana Piazza; Andrea Puppo; Sandra Salvi; Mauro Truini; Marina Gualco; Delia Mezzanzanica; Loredana Miglietta; Cristian Andreani; Simona Boccardo; Milena Bruzzone; Silvana Canevari; Maria Grazia Centurioni; Paolo Cristoforoni; Marina Fabbi; Silvano Ferrini
Interleukin (IL)-18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor.
International journal of cancer. Journal international du cancer 2011;129(5):1116-25.
2011: Franca Podo; Alessandro Ricci; Rossella Canese; Silvana Canevari; Maria Elena Pisanu; Egidio Iorio
MR evaluation of response to targeted treatment in cancer cells.
NMR in biomedicine 2011;24(6):648-72.
2010: Delia Mezzanzanica; Marina Bagnoli; Loris De Cecco; Barbara Valeri; Silvana Canevari
Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications.
The international journal of biochemistry & cell biology 2010;42(8):1262-72.
2010: Ileana Bortolomai; Silvana Canevari; Ileana Facetti; Loris De Cecco; Giancarlo Castellano; Alberto Zacchetti; Malcolm R Alison; Silvia Miotti
Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.
Cell cycle (Georgetown, Tex.) 2010;9(6):1194-206.
2010: Giancarlo Castellano; Elena Torrisi; Giovanni Ligresti; Ferdinando Nicoletti; Grazia Malaponte; Salvatore Traval; James A McCubrey; Silvana Canevari; Massimo Libra
Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression.
Cell cycle (Georgetown, Tex.) 2010;9(3):557-63.
2010: Marina Bagnoli; Silvana Canevari; Delia Mezzanzanica
Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer.
The international journal of biochemistry & cell biology 2010;42(2):210-3.
2009: Alberto Zacchetti; Angela Coliva; Elena Luison; Ettore Seregni; Emilio Bombardieri; Augusto Giussani; Mariangela Figini; Silvana Canevari
(177)Lu- labeled MOv18 as compared to (131)I- or (90)Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts.
Nuclear medicine and biology 2009;36(7):759-70.
2009: Marina Bagnoli; Federico Ambrogi; Silvana Pilotti; Paola Alberti; Antonino Ditto; Mattia Barbareschi; Enzo Galligioni; Elia Biganzoli; Silvana Canevari; Delia Mezzanzanica
c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome.
Endocrine-related cancer 2009;16(2):443-53.
2009: Giancarlo Castellano; Elena Torrisi; Giovanni Ligresti; Grazia Malaponte; Loredana Militello; Alessia E Russo; James A McCubrey; Silvana Canevari; Massimo Libra
The involvement of the transcription factor Yin Yang 1 in cancer development and progression.
Cell cycle (Georgetown, Tex.) 2009;8(9):1367-72.
2009: Mariangela Figini; Franck Martin; Renata Ferri; Elena Luison; Elena Ripamonti; Alberto Zacchetti; Mimosa Mortarino; Vito Di Cioccio; Giovanni Maurizi; Marcello Allegretti; Silvana Canevari
Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor.
Cancer immunology, immunotherapy : CII 2009;58(4):531-46.
2008: Antonella Tomassetti; Giuseppina De Santis; Giancarlo Castellano; Silvia Miotti; Mimma Mazzi; Daniela Tomasoni; Frans Van Roy; Maria Luisa Carcangiu; Silvana Canevari
Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells.
Neoplasia (New York, N.Y.) 2008;10(12):1481-92, 3p following 1492.
2008: Giancarlo Castellano; Grazia Malaponte; Maria C Mazzarino; Mariangela Figini; Francesco Marchese; Pietro Gangemi; Salvatore Travali; Franca Stivala; Silvana Canevari; Massimo Libra
Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7470-80.
2008: Francesca Spadaro; Carlo Ramoni; Delia Mezzanzanica; Silvia Miotti; Paola Alberti; Serena Cecchetti; Egidio Iorio; Vincenza Dolo; Silvana Canevari; Franca Podo
Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells.
Cancer research 2008;68(16):6541-9.
2008: Lidia Moserle; Stefano Indraccolo; Margherita Ghisi; Chiara Frasson; Elena Fortunato; Silvana Canevari; Silvia Miotti; Valeria Tosello; Rita Zamarchi; Alberto Corradin; Sonia Minuzzo; Elisabetta Rossi; Giuseppe Basso; Alberto Amadori
The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects.
Cancer research 2008;68(14):5658-68.
2008: Delia Mezzanzanica; Marina Fabbi; Marina Bagnoli; Samantha Staurengo; Marco Losa; Emanuela Balladore; Paola Alberti; Lara Lusa; Antonino Ditto; Silvano Ferrini; Marco A Pierotti; Mattia Barbareschi; Silvana Pilotti; Silvana Canevari
Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(6):1726-33.
2007: Ombretta Rosso; Tiziana Piazza; Italia Bongarzone; Armando Rossello; Delia Mezzanzanica; Silvana Canevari; Anna Maria Orengo; Andrea Puppo; Silvano Ferrini; Marina Fabbi
The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells.
Molecular cancer research : MCR 2007;5(12):1246-53.
2007: Fabio Turatti; Mariangela Figini; Emanuela Balladore; Paola Alberti; Patrizia Casalini; James D Marks; Silvana Canevari; Delia Mezzanzanica
Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interaction.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(7):684-93.
2007: Elena Sanna; Silvia Miotti; Mimma Mazzi; Giuseppina De Santis; Silvana Canevari; Antonella Tomassetti
Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells.
Experimental cell research 2007;313(7):1307-17.
2007: Marina Bagnoli; Emanuela Balladore; Elena Luison; Paola Alberti; Francesco Raspagliesi; Barbara Marcomini; Silvana Canevari; Delia Mezzanzanica
Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatment.
Molecular cancer therapeutics 2007;6(2):762-72.
2006: Giancarlo Castellano; James F Reid; Paola Alberti; Maria Luisa Carcangiu; Antonella Tomassetti; Silvana Canevari
New potential ligand-receptor signaling loops in ovarian cancer identified in multiple gene expression studies.
Cancer research 2006;66(22):10709-19.
2006: Giacomo Buscemi; Luigi Carlessi; Laura Zannini; Sofia Lisanti; Enrico Fontanella; Silvana Canevari; Domenico Delia
DNA damage-induced cell cycle regulation and function of novel Chk2 phosphoresidues.
Molecular and cellular biology 2006;26(21):7832-45.
2006: Kosei Hasegawa; Takafumi Nakamura; Mary Harvey; Yasuhiro Ikeda; Ann Oberg; Mariangela Figini; Silvana Canevari; Lynn C Hartmann; Kah-Whye Peng
The use of a tropism-modified measles virus in folate receptor-targeted virotherapy of ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 1):6170-8.
2006: Michael H Kershaw; Jennifer A Westwood; Linda L Parker; Gang Wang; Zelig Eshhar; Sharon A Mavroukakis; Donald E White; John R Wunderlich; Silvana Canevari; Linda Rogers-Freezer; Clara C Chen; James C Yang; STEVEN ROSENBERG; Patrick Hwu
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 1):6106-15.
2006: Daniela Aldovini; Francesca Demichelis; Claudio Doglioni; Dolores Di Vizio; Enzo Galligioni; Sonia Brugnara; Bruna Zeni; Claudia Griso; Cristina Pegoraro; Marina Zannoni; manuela gariboldi; Emanuela Balladore; Delia Mezzanzanica; Silvana Canevari; Mattia Barbareschi
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer.
International journal of cancer. Journal international du cancer 2006;119(8):1920-6.
2006: Silvana Canevari; manuela gariboldi; James F Reid; Italia Bongarzone; Marco A Pierotti
Molecular predictors of response and outcome in ovarian cancer.
Critical reviews in oncology/hematology 2006;60(1):19-37.
2006: Paolo Macor; Delia Mezzanzanica; Chiara Cossetti; Paola Alberti; Mariangela Figini; Silvana Canevari; Francesco Tedesco
Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma.
Cancer research 2006;66(7):3876-83.
2005: Angela Coliva; Alberto Zacchetti; Elena Luison; Antonella Tomassetti; Italia Bongarzone; Ettore Seregni; Emilio Bombardieri; Franck Martin; Augusto Giussani; Mariangela Figini; Silvana Canevari
90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas.
Cancer immunology, immunotherapy : CII 2005;54(12):1200-13.
2005: Silvia Miotti; Antonella Tomassetti; Ileana Facetti; Elena Sanna; Valeria Berno; Silvana Canevari
Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases.
The American journal of pathology 2005;167(5):1411-27.
2005: Egidio Iorio; Delia Mezzanzanica; Paola Alberti; Francesca Spadaro; Carlo Ramoni; Sandra D'Ascenzo; Danilo Millimaggi; Antonio Pavan; Vincenza Dolo; Silvana Canevari; Franca Podo
Alterations of choline phospholipid metabolism in ovarian tumor progression.
Cancer research 2005;65(20):9369-76.
2005: Tiziana Piazza; Emanuela Cha; Italia Bongarzone; Silvana Canevari; Andrea Bolognesi; Letizia Polito; Antonio Bargellesi; Francesca Sassi; Silvano Ferrini; Marina Fabbi
Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody.
Journal of cell science 2005;118(Pt 7):1515-25.
2005: Fabio Turatti; Mariangela Figini; Paola Alberti; Ralph A Willemsen; Silvana Canevari; Delia Mezzanzanica
Highly efficient redirected anti-tumor activity of human lymphocytes transduced with a completely human chimeric immune receptor.
The journal of gene medicine 2005;7(2):158-70.
2004: Silvia Arpicco; Silvana Canevari; Maurizio Ceruti; Enrico Galmozzi; Flavio Rocco; Luigi Cattel
Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids.
Farmaco (Società chimica italiana : 1989) 2004;59(11):869-78.
2004: Loris De Cecco; LUIGI MARCHIONNI; manuela gariboldi; James F Reid; M Stefania Lagonigro; Stefano Caramuta; Cristina Ferrario; Erica Bussani; Delia Mezzanzanica; Fabio Turatti; Domenico Delia; Maria Grazia Daidone; Maria Oggionni; Norma Bertuletti; Antonino Ditto; Francesco Raspagliesi; Silvana Pilotti; Marco A Pierotti; Silvana Canevari; Claudio Schneider
Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2.
Oncogene 2004;23(49):8171-83.
2004: Alessia Gaggero; Alessandro De Ambrosis; Delia Mezzanzanica; Tiziana Piazza; Anna Rubartelli; Mariangela Figini; Silvana Canevari; Silvano Ferrini
A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 processing.
Oncogene 2004;23(45):7552-60.
2004: Delia Mezzanzanica; Emanuela Balladore; Fabio Turatti; Elena Luison; Paola Alberti; Marina Bagnoli; Mariangela Figini; Alessandra Mazzoni; Francesco Raspagliesi; Maria Oggionni; Silvana Pilotti; Silvana Canevari
CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5202-14.
2004: S Violini; Sandra D'Ascenzo; Danilo Millimaggi; Silvia Miotti; Silvana Canevari; Antonio Pavan; Vincenza Dolo
Induction of a multifactorial resistance phenotype by high paclitaxel selective pressure in a human ovarian carcinoma cell line.
Journal of experimental & clinical cancer research : CR 2004;23(1):83-91.
2003: Mariangela Figini; R Ferri; Delia Mezzanzanica; Marina Bagnoli; Elena Luison; Silvia Miotti; Silvana Canevari
Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies.
Gene therapy 2003;10(12):1018-25.
2003: Emanuela Roccato; Sonia Pagliardini; Loredana Cleris; Silvana Canevari; Franca Formelli; Marco A Pierotti; Angela Greco
Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation.
Oncogene 2003;22(6):807-18.
2003: Antonella Tomassetti; Fabio Mangiarotti; Mimma Mazzi; Sabrina Sforzini; Silvia Miotti; Enrico Galmozzi; Patrick C Elwood; Silvana Canevari
The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinoma.
Cancer research 2003;63(3):696-704.
2003: Marina Bagnoli; Silvana Canevari; Mariangela Figini; Delia Mezzanzanica; Francesco Raspagliesi; Antonella Tomassetti; Silvia Miotti
A step further in understanding the biology of the folate receptor in ovarian carcinoma.
Gynecologic oncology 2003;88(1 Pt 2):S140-4.
2003: Mariangela Figini; Andrew Green; Francesco Colotta; Silvana Canevari
Isolation of human Fab fragments against ovarian carcinoma using guided selection.
Methods in molecular biology (Clifton, N.J.) 2003;207():145-59.
2002: Silvana Canevari; Silvia Biocca; Mariangela Figini
Re: Blocking oncogenic Ras signaling for cancer therapy.
Journal of the National Cancer Institute 2002;94(13):1031-2; author reply 1032.
2002: Zhao Yuan Wang; Alessia Gaggero; Anna Rubartelli; Ombretta Rosso; Silvia Miotti; Delia Mezzanzanica; Silvana Canevari; Silvano Ferrini
Expression of interleukin-18 in human ovarian carcinoma and normal ovarian epithelium: evidence for defective processing in tumor cells.
International journal of cancer. Journal international du cancer 2002;98(6):873-8.
2002: Mariangela Figini; Silvana Canevari
Isolation of human monoclonal antibodies using guided selection with mouse monoclonal antibodies.
Methods in molecular biology (Clifton, N.J.) 2002;178():207-17.
2002: Isabelle Renard; Delia Mezzanzanica; Silvana Canevari; Silvano Ferrini; Jacques Boniver; Philippe Delvenne; Nathalie Jacobs
Anti-CD3/anti-epidermal growth factor receptor-bispecific antibody retargeting of lymphocytes against human neoplastic keratinocytes in an autologous organotypic culture model.
The American journal of pathology 2002;160(1):113-22.
2001: ME Perico; Marco Chinol; A Nacca; Elena Luison; G Paganelli; Silvana Canevari
The humoral immune response to macrocyclic chelating agent DOTA depends on the carrier molecule.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(11):1697-703.
2001: Enrico Galmozzi; Antonella Tomassetti; Sabrina Sforzini; Fabio Mangiarotti; Mimma Mazzi; K Nachmanoff; P C Elwood; Silvana Canevari
Exon 3 of the alpha folate receptor gene contains a 5' splice site which confers enhanced ovarian carcinoma specific expression.
FEBS letters 2001;502(1-2):31-4.
2001: DR Negri; Delia Mezzanzanica; S Sacco; M Gadina; F Benigni; Laura Cajola; G Finocchiaro; Pietro Ghezzi; Silvana Canevari
Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.
Cytokine 2001;15(1):27-38.
2001: Valentina Appierto; Elena Cavadini; R Pergolizzi; Loredana Cleris; R Lotan; Silvana Canevari; Franca Formelli
Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line.
British journal of cancer 2001;84(11):1528-34.
2001: Fabio Turatti; Delia Mezzanzanica; E Nardini; Elena Luison; Lorenzo Maffioli; E Bambardieri; C de Lalla; Silvana Canevari; Mariangela Figini
Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2.
Cancer immunology, immunotherapy : CII 2001;49(12):679-86.
2001: Fabio Mangiarotti; Silvia Miotti; Enrico Galmozzi; Mimma Mazzi; Sabrina Sforzini; Silvana Canevari; Antonella Tomassetti
Functional effect of point mutations in the alpha-folate receptor gene of CABA I ovarian carcinoma cells.
Journal of cellular biochemistry 2001;81(3):488-98.
2001: Silvano Ferrini; Sabrina Sforzini; Silvana Canevari
Bispecific monoclonal antibodies for the targeting of type I ribosome-inactivating proteins against hematological malignancies.
Methods in molecular biology (Clifton, N.J.) 2001;166():177-92.
2000: Marina Bagnoli; Antonella Tomassetti; Mariangela Figini; Silvio Flati; Vincenza Dolo; Silvana Canevari; Silvia Miotti
Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression.
Oncogene 2000;19(41):4754-63.
2000: ME Perico; Delia Mezzanzanica; Elena Luison; Paola Alberti; L Panza; G Russo; Silvana Canevari
Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1.
Cancer immunology, immunotherapy : CII 2000;49(6):296-304.
2000: Silvia Miotti; Marina Bagnoli; Antonella Tomassetti; MI Colnaghi; Silvana Canevari
Interaction of folate receptor with signaling molecules lyn and G(alpha)(i-3) in detergent-resistant complexes from the ovary carcinoma cell line IGROV1.
Journal of cell science 2000;113 Pt 2():349-57.
1999: E Adobati; A Zacchetti; ME Perico; Fausto Cremonesi; Guido Rasi; P S Vallebona; Muriel A Hagenaars; Peter Kuppen; Ira Pastan; L Panza; G Russo; MI Colnaghi; Silvana Canevari
Expression profile of saccharide epitope CaMBr1 in normal and neoplastic tissue from dogs, cats, and rats: implication for the development of human-derived cancer vaccines.
The Histochemical journal 1999;31(11):729-37.
1999: F Neglia; Anna Maria Orengo; Michele Cilli; Raffaella Meazza; Antonella Tomassetti; Silvana Canevari; Cecilia Melani; Mario P Colombo; Silvano Ferrini
DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in mice.
Cancer gene therapy 1999;6(4):349-57.
1999: Vincenza Dolo; Sandra D'Ascenzo; S Violini; L Pompucci; Claudio Festuccia; Angela Ginestra; M Letizia Vittorelli; Silvana Canevari; Antonio Pavan
Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro.
Clinical & experimental metastasis 1999;17(2):131-40.
1999: Silvia Miotti; DR Negri; O Valota; M Calabrese; R L Bolhuis; J W Gratama; MI Colnaghi; Silvana Canevari
Level of anti-mouse-antibody response induced by bi-specific monoclonal antibody OC/TR in ovarian-carcinoma patients is associated with longer survival.
International journal of cancer. Journal international du cancer 1999;84(1):62-8.
1999: Franco Dosio; Silvia Arpicco; Silvana Canevari; Mariangela Figini; D Gastaldi
Single-step purification of immunotoxins containing a high ionic charge ribosome inactivating protein clavin by carboxymethyl high-performance membrane chromatography.
Journal of chromatography. A 1999;830(2):329-35.
1999: Antonella Tomassetti; F Bottero; Mimma Mazzi; Silvia Miotti; MI Colnaghi; Silvana Canevari
Molecular requirements for attachment of the glycosylphosphatidylinositol anchor to the human alpha folate receptor.
Journal of cellular biochemistry 1999;72(1):111-8.
1998: Monica Rodolfo; Cecilia Melani; C Zilocchi; B Cappetti; Elena Luison; Ivano Arioli; Mariella Parenza; Silvana Canevari; Mario P Colombo
IgG2a induced by interleukin (IL) 12-producing tumor cell vaccines but not IgG1 induced by IL-4 vaccine is associated with the eradication of experimental metastases.
Cancer research 1998;58(24):5812-7.
1998: Delia Mezzanzanica; Silvana Canevari; Alessandra Mazzoni; Mariangela Figini; MI Colnaghi; Tova Waks; Daniel G Schindler; Zelig Eshhar
Transfer of chimeric receptor gene made of variable regions of tumor-specific antibody confers anticarbohydrate specificity on T cells.
Cancer gene therapy 1998;5(6):401-7.
1998: Vincenza Dolo; Angela Ginestra; D Cassarà; S Violini; Giuseppe Lucania; Maria Rosaria Torrisi; H Nagase; Silvana Canevari; Antonio Pavan; M Letizia Vittorelli
Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells.
Cancer research 1998;58(19):4468-74.
1998: Cecilia Melani; Mariangela Figini; D Nicosia; Elena Luison; V Ramakrishna; G Casorati; Giorgio Parmiani; Zelig Eshhar; Silvana Canevari; Mario P Colombo
Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody.
Cancer research 1998;58(18):4146-54.
1998: Sabrina Sforzini; Daniela de Totero; Alessia Gaggero; R Ippoliti; M J Glennie; Silvana Canevari; H Stein; Silvano Ferrini
Targeting of saporin to Hodgkin's lymphoma cells by anti-CD30 and anti-CD25 bispecific antibodies.
British journal of haematology 1998;102(4):1061-8.
1998: Marco Chinol; Patrizia Casalini; M Maggiolo; Silvana Canevari; E S Omodeo; Paolo Caliceti; Francesco M Veronese; Marta Cremonesi; F Chiolerio; E Nardone; Antonio G Siccardi; Giovanni Paganelli
Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity.
British journal of cancer 1998;78(2):189-97.
1998: Franco Dosio; Silvia Arpicco; E Adobati; Silvana Canevari; Paola Brusa; Rita De Santis; D Parente; P Pignanelli; DR Negri; M I Colnaghi; Luigi Cattel
Role of cross-linking agents in determining the biochemical and pharmacokinetic properties of Mgr6-clavin immunotoxins.
Bioconjugate chemistry 1998;9(3):372-81.
1998: Mariangela Figini; L Obici; Delia Mezzanzanica; A Griffiths; MI Colnaghi; G Winter; Silvana Canevari
Panning phage antibody libraries on cells: isolation of human Fab fragments against ovarian carcinoma using guided selection.
Cancer research 1998;58(5):991-6.
1997: Silvana Canevari; Delia Mezzanzanica; Alessandra Mazzoni; DR Negri; Mariangela Figini; V Ramakrishna; G Bolis; MI Colnaghi
Approaches to implement bispecific antibody treatment of ovarian carcinoma.
Cancer immunology, immunotherapy : CII 1997;45(3-4):187-9.
1997: V Ramakrishna; DR Negri; V Brusic; R Fontanelli; Silvana Canevari; G Bolis; Chiara Castelli; Giorgio Parmiani
Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cells.
International journal of cancer. Journal international du cancer 1997;73(1):143-50.
1997: Patrizia Casalini; Elena Luison; S Ménard; MI Colnaghi; G Paganelli; Silvana Canevari
Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(9):1378-81.
1997: Nathalie Jacobs; Alessandra Mazzoni; Delia Mezzanzanica; DR Negri; O Valota; MI Colnaghi; Michel Moutschen; Jacques Boniver; Silvana Canevari
Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generation.
Cancer immunology, immunotherapy : CII 1997;44(5):257-64.
1997: Silvia Miotti; Marina Bagnoli; F Ottone; Antonella Tomassetti; MI Colnaghi; Silvana Canevari
Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines.
Journal of cellular biochemistry 1997;65(4):479-91.
1997: C Botti; DR Negri; Ettore Seregni; V Ramakrishna; Flavio Arienti; Lorenzo Maffioli; C Lombardo; Anna Bogni; Claudio Pascali; Flavio Crippa; S Massaron; F Remonti; S Nerini-Molteni; Silvana Canevari; Emilio Bombardieri
Comparison of three different methods for radiolabelling human activated T lymphocytes.
European journal of nuclear medicine 1997;24(5):497-504.
1997: E Adobati; L Panza; G Russo; MI Colnaghi; Silvana Canevari
In vitro mimicry of CaMBr1 tumor-associated antigen by synthetic oligosaccharides.
Glycobiology 1997;7(2):173-8.
1997: Vincenza Dolo; Angela Ginestra; S Violini; Silvia Miotti; Claudio Festuccia; D Miceli; Manuela Migliavacca; C Rinaudo; F M Romano; F Brisdelli; Silvana Canevari; Antonio Pavan; M Letizia Vittorelli
Ultrastructural and phenotypic characterization of CABA I, a new human ovarian cancer cell line.
Oncology research 1997;9(3):129-38.
1996: Alessandra Mazzoni; Delia Mezzanzanica; G Jung; H Wolf; MI Colnaghi; Silvana Canevari
CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.
Cancer research 1996;56(23):5443-9.
1996: D Parente; Giuseppe Raucci; B Celano; A Pacilli; L Zanoni; Silvana Canevari; E Adobati; MI Colnaghi; Franco Dosio; Silvia Arpicco; Luigi Cattel; Alfonso Mele; Rita De Santis
Clavin, a type-1 ribosome-inactivating protein from Aspergillus clavatus IFO 8605. cDNA isolation, heterologous expression, biochemical and biological characterization of the recombinant protein.
European journal of biochemistry / FEBS 1996;239(2):272-80.
1996: E Tosi; O Valota; Silvana Canevari; E Adobati; Patrizia Casalini; P Perez; MI Colnaghi
Anti-idiotypic response to antigrowth factor receptor monoclonal antibodies.
European journal of cancer (Oxford, England : 1990) 1996;32A(3):498-505.
1996: Silvana Canevari; Serenella M Pupa; Sylvie Ménard
1975-1995 revised anti-cancer serological response: biological significance and clinical implications.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(3):227-32.
1996: S Sen; E Erba; M D'Incalci; F Bottero; Silvana Canevari; Antonella Tomassetti
Role of membrane folate-binding protein in the cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cell lines in vitro.
British journal of cancer 1996;73(4):525-30.
1995: Silvia Miotti; P Facheris; Antonella Tomassetti; F Bottero; C Bottini; F Ottone; MI Colnaghi; Marlene A Bunni; D G Priest; Silvana Canevari
Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivo.
International journal of cancer. Journal international du cancer 1995;63(3):395-401.
1995: Silvana Canevari; G Stoter; F Arienti; Giorgio Bolis; MI Colnaghi; E M Di Re; Alexander M M Eggermont; Swan Hoo Goey; J W Gratama; C H Lamers
Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody.
Journal of the National Cancer Institute 1995;87(19):1463-9.
1995: F Benigni; Silvana Canevari; M Gadina; E Adobati; A J Ferreri; E F Di Celle; R Comolli; MI Colnaghi
Preclinical evaluation of the ribosome-inactivating proteins PAP-1, PAP-S and RTA in mice.
International journal of immunopharmacology 1995;17(10):829-39.
1995: Silvana Canevari; Delia Mezzanzanica; Alessandra Mazzoni; DR Negri; V Ramakrishna; R L Bolhuis; MI Colnaghi; G Bolis
Bispecific antibody targeted T cell therapy of ovarian cancer: clinical results and future directions.
Journal of hematotherapy 1995;4(5):423-7.
1995: DR Negri; E Tosi; O Valota; Silvano Ferrini; A Cambiaggi; Sabrina Sforzini; Antonio Silvani; P A Ruffini; MI Colnaghi; Silvana Canevari
In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.
British journal of cancer 1995;72(4):928-33.
1995: E Tosi; O Valota; DR Negri; E Adobati; Alessandra Mazzoni; R Meazza; Silvano Ferrini; MI Colnaghi; Silvana Canevari
Anti-tumor efficacy of an anti-epidermal-growth-factor-receptor monoclonal antibody and its F(ab')2 fragment against high- and low-EGFR-expressing carcinomas in nude mice.
International journal of cancer. Journal international du cancer 1995;62(5):643-50.
1995: Vincenza Dolo; E Adobati; Silvana Canevari; M A Picone; M Letizia Vittorelli
Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens.
Clinical & experimental metastasis 1995;13(4):277-86.
1995: Patrizia Casalini; Delia Mezzanzanica; O Valota; E Adobati; Antonella Tomassetti; MI Colnaghi; Silvana Canevari
Unidirectional potentiation of binding between two anti-FBP MAbs: evaluation of the involved mechanisms.
Journal of cellular biochemistry 1995;58(1):47-55.
1994: Silvana Canevari; M Colombatti; MI Colnaghi
Immunoconjugates: lessons from animal models.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(8):698-701.
1994: Silvano Ferrini; Sabrina Sforzini; A Cambiaggi; Alessandro Poggi; Raffaella Meazza; Silvana Canevari; MI Colnaghi; Lorenzo Moretta
The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes.
International journal of cancer. Journal international du cancer 1994;56(6):846-52.
1994: L T Mantovani; Silvia Miotti; Sylvie Ménard; Silvana Canevari; Francesco Raspagliesi; C Bottini; F Bottero; MI Colnaghi
Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19.
European journal of cancer (Oxford, England : 1990) 1994;30A(3):363-9.
1993: Silvano Ferrini; A Cambiaggi; Sabrina Sforzini; S Marciano; Silvana Canevari; D Mezzanzanica; MI Colnaghi; C E Grossi; Lorenzo Moretta
Targeting of T lymphocytes against EGF-receptor+ tumor cells by bispecific monoclonal antibodies: requirement of CD3 molecule cross-linking for T-cell activation.
International journal of cancer. Journal international du cancer 1993;55(6):931-7.
1993: F Bottero; Antonella Tomassetti; Silvana Canevari; Silvia Miotti; Sylvie Ménard; MI Colnaghi
Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivo.
Cancer research 1993;53(23):5791-6.
1993: MI Colnaghi; Sylvie Ménard; Silvana Canevari
Evolution of the therapeutic use of new monoclonal antibodies.
Current opinion in oncology 1993;5(6):1035-42.
1993: Silvana Canevari; Silvia Miotti; F Bottero; O Valota; MI Colnaghi
Ovarian carcinoma therapy with monoclonal antibodies.
Hybridoma 1993;12(5):501-7.
1993: Silvana Canevari; D Furlan; A Mossa; Mariangela Figini
Monoclonal antibodies by genetic engineering: novel reagents for in vivo diagnosis and therapy.
The International journal of biological markers 1993;8(3):147-50.
1993: Patrizia Casalini; M Caldera; Silvana Canevari; Sylvie Ménard; Delia Mezzanzanica; E Tosi; M Gadina; MI Colnaghi
A critical comparison of three internalization assays applied to the evaluation of a given mAb as a toxin-carrier candidate.
Cancer immunology, immunotherapy : CII 1993;37(1):54-60.
1993: Antonella Tomassetti; L R Coney; Silvana Canevari; Silvia Miotti; P Facheris; V R Zurawski; MI Colnaghi
Isolation and biochemical characterization of the soluble and membrane forms of folate binding protein expressed in the ovarian carcinoma cell line IGROV1.
FEBS letters 1993;317(1-2):143-6.
1993: Silvano Ferrini; A Cambiaggi; Sabrina Sforzini; Silvana Canevari; D Mezzanzanica; MI Colnaghi; Lorenzo Moretta
Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells.
Cancer detection and prevention 1993;17(2):295-300.
1993: F Perrone; Sylvie Ménard; Silvana Canevari; M Calabrese; P Boracchi; Rosaria Bufalino; S Testori; M Baldini; MI Colnaghi
Prognostic significance of the CaMBr1 antigen on breast carcinoma: relevance of the type of recognised glycoconjugate.
European journal of cancer (Oxford, England : 1990) 1993;29A(15):2113-7.
1992: Rosaria Orlandi; Mariangela Figini; Antonella Tomassetti; Silvana Canevari; MI Colnaghi
Characterization of a mouse-human chimeric antibody to a cancer-associated antigen.
International journal of cancer. Journal international du cancer 1992;52(4):588-93.
1992: Silvano Ferrini; C Cantoni; A Cambiaggi; Q Chen; P Venzano; Silvana Canevari; MI Colnaghi; Lorenzo Moretta
Induction of anti-tumor immune response by bispecific monoclonal antibodies (bimAbs).
Pharmacological research : the official journal of the Italian Pharmacological Society 1992;26 Suppl 2():146-7.
1992: A J Ferreri; E Ferraris di Celle; M Caldera; S Muñoz; S Salvarelli; F Conde; Silvana Canevari; E Tosi; MI Colnaghi
Production and characterization of a monoclonal antibody against the ribosome inactivating protein alpha sarcin.
Hybridoma 1992;11(4):437-46.
1992: Silvia Miotti; Saverio Alberti; P Facheris; L Mantovani; M Fornaro; M Stella; Sylvie Ménard; Silvana Canevari; MI Colnaghi
Membrane association and shedding of the GPI-anchored Ca-MOv18 antigen in human ovary carcinoma cells.
International journal of cancer. Journal international du cancer 1992;51(3):499-505.
1992: F Leoni; MI Colnaghi; Silvana Canevari; Sylvie Ménard; E Colzani; P Facheris; Mariangela Figini; Silvia Miotti; J L Magnani
Glycolipids carrying Le(y) are preferentially expressed on small-cell lung cancer cells as detected by the monoclonal antibody MLuC1.
International journal of cancer. Journal international du cancer 1992;51(2):225-31.
1992: P Facheris; F Perrone; Sylvie Ménard; S Andreola; P Bazzini; Rosaria Bufalino; Silvana Canevari; Natale Cascinelli; E Colzani; G Di Fronzo
Study of the biological and prognostic significance of the antigen CaMBr8 on breast carcinoma.
British journal of cancer 1992;65(3):466-70.
1992: Silvana Canevari; D Mezzanzanica; Sylvie Ménard; S Ferrini; L Moretta; MI Colnaghi
Possible targets on carcinoma for bMAb retargeting of lymphocyte or drug cytotoxicity.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1992;7():42-4.
1992: Silvano Ferrini; A Cambiaggi; C Cantoni; Silvana Canevari; D Mezzanzanica; MI Colnaghi; Lorenzo Moretta
Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1992;7():15-8.
1991: Patrizia Casalini; Delia Mezzanzanica; Silvana Canevari; G Della Torre; Silvia Miotti; MI Colnaghi; S Matzku
Use of combination of monoclonal antibodies directed against three distinct epitopes of a tumor-associated antigen: analysis of cell binding and internalization.
International journal of cancer. Journal international du cancer 1991;48(2):284-90.
1991: T Cogliati; Paola Brusa; Silvana Canevari; M Caldera; Delia Mezzanzanica; Franco Dosio; Luigi Cattel; MI Colnaghi
Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing MAb.
Anticancer research 1991;11(1):417-21.
1991: M Gadina; Silvana Canevari; M Ripamonti; M Mariani; MI Colnaghi
Preclinical pharmacokinetics and localization studies of the radioiodinated anti-ovarian carcinoma MAb MOv18.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(4):403-8.
1991: Flavio Crippa; G L Buraggi; E Di Re; M Gasparini; Ettore Seregni; Silvana Canevari; M Gadina; Mauro Presti; A Marini; E Seccamani
Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody.
European journal of cancer (Oxford, England : 1990) 1991;27(6):724-9.
1991: Delia Mezzanzanica; Silvana Canevari; MI Colnaghi
Retargeting of human lymphocytes against human ovarian carcinoma cells by bispecific antibodies: from laboratory to clinic.
International journal of clinical & laboratory research 1991;21(2):159-64.
1990: S M Muñoz; M Caldera; Silvana Canevari; E Tosi; T Cogliati; MI Colnaghi; F P Conde
Fractionation of the ribosome inactivating protein preparations with triazine dyes.
Biochemical and biophysical research communications 1990;173(2):554-60.
1990: Saverio Alberti; Silvia Miotti; M Fornaro; L Mantovani; S Walter; Silvana Canevari; S Menard; MI Colnaghi
The Ca-MOv18 molecule, a cell-surface marker of human ovarian carcinomas, is anchored to the cell membrane by phosphatidylinositol.
Biochemical and biophysical research communications 1990;171(3):1051-5.
1989: L Mantovani; V Azzini; Silvana Canevari; R Danzi; Rosanna Fontanelli; F Leoni; Sylvie Ménard; Silvia Miotti; M Pasquali; Milvia Zambetti
Detection of Lewis(a) antigen in sera of ovarian carcinoma patients by MOv2-MOv8 double-determinant radioimmunoassay.
The International journal of biological markers 1989;4(4):197-202.
1989: Sylvie Ménard; Silvana Canevari; MI Colnaghi
Hybrid antibodies in cancer diagnosis and therapy.
The International journal of biological markers 1989;4(3):131-4.
1989: F P Conde; Rosaria Orlandi; Silvana Canevari; Delia Mezzanzanica; M Ripamonti; S M Muñoz; P Jorge; MI Colnaghi
The Aspergillus toxin restriction is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells.
European journal of biochemistry / FEBS 1989;178(3):795-802.
1989: MI Colnaghi; G L Buraggi; Silvana Canevari; F Di Re; F Leoni; C Mangioni; Sylvie Ménard; Rosaria Orlandi
Evaluation of the suitability of a monoclonal antibody raised against human ovarian carcinoma for therapeutic approaches.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1989;16(6):633-6.
1988: M Ripamonti; Silvana Canevari; G Buraggi; M Gadina; A Turrin; M Gasparini; G Scassellati; MI Colnaghi
Monoclonal anti-CEA antibody: factors affecting localization in a preclinical study.
The International journal of biological markers 1988;3(4):249-58.
1988: Serenella M Pupa; Silvana Canevari; Rosanna Fontanelli; Sylvie Ménard; Delia Mezzanzanica; Antonio Lanzavecchia; MI Colnaghi
Activation of mononuclear cells to be used for hybrid monoclonal antibody-induced lysis of human ovarian carcinoma cells.
International journal of cancer. Journal international du cancer 1988;42(3):455-9.
1988: Delia Mezzanzanica; Silvana Canevari; Sylvie Ménard; Serenella M Pupa; Elda Tagliabue; Antonio Lanzavecchia; MI Colnaghi
Human ovarian carcinoma lysis by cytotoxic T cells targeted by bispecific monoclonal antibodies: analysis of the antibody components.
International journal of cancer. Journal international du cancer 1988;41(4):609-15.
1988: F Leoni; J L Magnani; Silvia Miotti; Silvana Canevari; M Pasquali; S Sonnino; MI Colnaghi
The antitumor monoclonal antibody MOv2 recognizes the Lewis A hapten.
Hybridoma 1988;7(2):129-39.
1988: R Alzani; Marco A Pierotti; Sylvie Ménard; Silvana Canevari; M L Fertonani; D Ballinari; Catia Traversari; Gabriella Della Torre; Paolo Radice; Silvana Pilotti
Monoclonal antibodies against NIH 3T3 cells transformed by human thyroid carcinoma DNA.
Hybridoma 1988;7(1):7-18.
1988: MI Colnaghi; Silvana Canevari; Sylvie Ménard
Monoclonal antibodies in immunodiagnosis and immunotherapy of human cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1988;14(1):1-7.
1988: Rosaria Orlandi; Silvana Canevari; F P Conde; F Leoni; Delia Mezzanzanica; M Ripamonti; MI Colnaghi
Immunoconjugate generation between the ribosome inactivating protein restrictocin and an anti-human breast carcinoma MAB.
Cancer immunology, immunotherapy : CII 1988;26(2):114-20.
1988: Silvana Canevari; Sylvie Ménard; Delia Mezzanzanica; Silvia Miotti; Serenella M Pupa; A Lanzavecchia; MI Colnaghi
Anti-ovarian carcinoma anti-T3 heteroconjugates or hybrid antibodies induce tumor cell lysis by cytotoxic T-cells.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1988;2():18-21.
1987: S Camagni; Silvana Canevari; M Ripamonti; Delia Mezzanzanica; Rosaria Orlandi; MI Colnaghi
The effect of human serum on the binding activity of radiolabelled monoclonal antibodies.
Tumori 1987;73(6):547-54.
1987: Silvia Miotti; Silvana Canevari; Sylvie Ménard; Delia Mezzanzanica; G Porro; Serenella M Pupa; M Regazzoni; Elda Tagliabue; MI Colnaghi
Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.
International journal of cancer. Journal international du cancer 1987;39(3):297-303.
1987: M Ripamonti; Silvana Canevari; Sylvie Ménard; Delia Mezzanzanica; Silvia Miotti; Rosaria Orlandi; F Rilke; Elda Tagliabue; MI Colnaghi
Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model.
Cancer immunology, immunotherapy : CII 1987;24(1):13-8.
1986: Rosaria Orlandi; Silvana Canevari; F Leoni; Delia Mezzanzanica; M Ripamonti; MI Colnaghi
Change in binding reactivity of an anti-tumor monoclonal antibody after the introduction of 2-pyridyl disulphide groups.
Hybridoma 1986;5(1):1-8.
1986: F Leoni; Silvia Miotti; Silvana Canevari; S Sonnino; M Ripamonti; MI Colnaghi
Carbohydrate epitope defined by an antitumor monoclonal antibody detected on glycoproteins and a glycolipid by immunoblotting.
Hybridoma 1986;5(4):289-96.
1985: Silvana Canevari; Rosaria Orlandi; M Ripamonti; Elda Tagliabue; S Aguanno; Silvia Miotti; S Menard; MI Colnaghi
Ricin A chain conjugated with monoclonal antibodies selectively killing human carcinoma cells in vitro.
Journal of the National Cancer Institute 1985;75(5):831-9.
1985: Silvia Miotti; S Aguanno; Silvana Canevari; A Diotti; Rosaria Orlandi; S Sonnino; MI Colnaghi
Biochemical analysis of human ovarian cancer-associated antigens defined by murine monoclonal antibodies.
Cancer research 1985;45(2):826-32.
1984: Elda Tagliabue; Silvana Canevari; S Menard; G Fossati; A Balsari; G Della Torre; MI Colnaghi
Human renal antigen defined by a murine monoclonal antibody.
Journal of the National Cancer Institute 1984;73(2):363-9.